Skip to content
TrialScanner

NCT04761198

A Study of Etigilimab and Nivolumab in Participants With Locally Advanced or Metastatic Tumors

Phase 1/Phase 2CompletedMREOLead

Registry record

Lead sponsor
Mereo BioPharma
Conditions
Solid Tumor, Adult; Advanced Solid Tumor; Metastatic Solid Tumor
Primary completion
Oct 30, 2023Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04761198 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04761198: A Study of Etigilimab and... | TrialScanner